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Introduction 
 
 Mastitis is the most prevalent and costly disease in dairy production  (between 65 and  182€ / cow ). 
 The main pathogens causing mastitis are S. agalactiae, S. dysgalactiae, S. uber, S. aureus and E. coli. 
 The prevalence in Spain is of 25% (Perez-Cabal et al., 2008). 
 Nowadays, the treatment of mastitis is based in the administration of antibiotics in two different productive moments: during lactation and dry 
period. Another option is the directed treatment. 
 Treatment with antibacterial has benefits but also involves an inherent risk of resistance appearances. 
Hypothesis and Objectives 
 
 Determine the situation and the therapeutic practice of mastitis. 
 Relate the results with the antibiotic used. 
 Evaluate the relative importance of mastitis and antibiotic in milk 
production. 
 Evaluate the risks of antibiotics according to operating practices. 
 
 
Material and Methods 
 
 A  survey was answered  by farmers of six dairy farms located in different 
areas of Catalonia. 
 The survey  is composed in three parts: general dates, mastitis and 
antibiotic use.  
 
Results and Discussion 
 
 Prevalence of mastitis  was 46%  with  26% of repetitions . High C.V.  
 Drying routine treatment in 5 of the 6 farms. 
 Clinical mastitis selection criterion is effectiveness. 
 Use of antibiotics in lameness, displaced abomasum, metritis, 
pneumonia and placenta retention (depending on the farm). 
 No rotation of antibiotics. 
 In 4 of the 6 farms the prescriptor of the recipes wasn’t the clinical 
veterinary of the exploitation. 
 There is a tendency to abuse of antibiotics management (without 
defined criteria). Farmers are unaware of the risks or economic losses 
that can generate the abuse of antibiotics. Data poorly recorded. 
 Management and feeding are the most important productive and 
economic factors 
 Sample is too small to get certain trends. 
 
Conclusions 
 
   Reducing antibiotic use: 
         -   No treatment routine in dry period. 
         -   Targeted therapy in clinical mastitis  
         -   Good practice guides for each antibiotic and pathogen. 
         -   Vaccination 
         -   Antibiotic rotation 
   Data collection, monitoring and control of mastitis 
   Formation of the farmers 
   Prescription of recipes from the clinic veterinary 
   Official records by the administration 
   Development of new drugs 
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